![](/img/cover-not-exists.png)
77PPreliminary results from a phase 1 study of AB122, a programmed cell death-1 (PD-1) inhibitor, in patients with advanced solid malignancies
Seitz, L C, Rieger, A, Berry, W, Ashok, D, Direnzo, D, Jin, L, Lee, S J, Park, A, Piovesan, D, Tan, J B L, Walters, M J, Karakunnel, JVolume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy487.008
Date:
December, 2018
File:
PDF, 77 KB
2018